Cancer vaccines containing epitopes of oncofetal antigen
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 29, 2014
Issued Date -
N/A
app pub date -
Aug 5, 2009
filing date -
Aug 2, 2002
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Disclosed are fragments of oncofetal antigen, otherwise known as immature laminin receptor protein that specifically stimulate one T cell subclass. The fragments may be formulated into compositions for potentiating T cell-mediated responses in mammalian cancer patients. They also have therapeutic uses in vitro.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully